UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Act of 1934
Date of Report (Date of earliest event reported)
December 2, 2004
OCEAN BIO-CHEM, INC.
Florida 2-70197 59-1564329
-------- -------- --------------
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification
Incorporation) Number)
4041 S.W. 47 Avenue
Fort Lauderdale, Florida 3314
(Address of Principal Executive Offices) (Zip Code)
(954) 587-6280
(Registrant's telephone number, including area code)
(Former name of Registrant, if changed since last report)
N/A
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the Registrant under any of the
following provisions:
( ) Written communication pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
( ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
( ) Pre-commencement communication pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
( ) Pre-commencement communication pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On December 2, 2004 the Company issued a press release reporting that the
Board of Directors of the Company had authorized a Stock Repurchase Program. The
terms of the program, intended to comply with Rule 10b-18, contemplates
repurchases of Company stock when available at or below the Company's book value
and with a maximum expenditure of $50,000 by the Company. The program is
authorized for six months unless extended by the Board of Directors.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Ocean Bio-Chem, Inc.
/s/ Peter G. Dornau
-------------------------------------
Peter G. Dornau
Chairman of the Board and
Chief Executive Officer